Professional Documents
Culture Documents
MEDICAL MICROBIOLOGY
L. Barth Reller and Melvin P. Weinstein, Section Editors
Department of Pathology, The University of Texas Health Science Center, San Antonio; and Departments of 2Pathology and 3Medicine, Massachusetts General
Hospital and Harvard Medical School, Boston
Received 8 May 2009; accepted 27 July 2009; electronically published 26 October 2009.
Reprints or correspondence: Dr James H. Jorgensen, Dept of Pathology, University of Texas
Health Science Center, 7703 Floyd Curl Dr, San Antonio, TX 78229-7750 (jorgensen@
uthscsa.edu).
Clinical Infectious Diseases 2009; 49:174955
2009 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2009/4911-0022$15.00
DOI: 10.1086/647952
An important task of the clinical microbiology laboratory is the performance of antimicrobial susceptibility testing of
significant bacterial isolates. The goals of testing are to detect possible drug resistance in common pathogens and to assure
susceptibility to drugs of choice for particular infections. The most widely used testing methods include broth microdilution
or rapid automated instrument methods that use commercially marketed materials and devices. Manual methods that provide
flexibility and possible cost savings include the disk diffusion and gradient diffusion methods. Each method has strengths
and weaknesses, including organisms that may be accurately tested by the method. Some methods provide quantitative results
(eg, minimum inhibitory concentration), and all provide qualitative assessments using the categories susceptible, intermediate,
or resistant. In general, current testing methods provide accurate detection of common antimicrobial resistance mechanisms.
However, newer or emerging mechanisms of resistance require constant vigilance regarding the ability of each test method
to accurately detect resistance.
Figure 1. A broth microdilution susceptibility panel containing 98 reagent wells and a disposable tray inoculator
dilution testing [10] are applied to Etest MICs that may not
be identical.
Disk diffusion test. The disk diffusion susceptibility
method [2, 11, 12] is simple and practical and has been wellstandardized. The test is performed by applying a bacterial
inoculum of approximately 12 10 8 CFU/mL to the surface
of a large (150 mm diameter) Mueller-Hinton agar plate. Up
to 12 commercially-prepared, fixed concentration, paper antibiotic disks are placed on the inoculated agar surface (Figure
3). Plates are incubated for 1624 h at 35C prior to determination of results. The zones of growth inhibition around
each of the antibiotic disks are measured to the nearest millimeter. The diameter of the zone is related to the susceptibility
of the isolate and to the diffusion rate of the drug through the
agar medium. The zone diameters of each drug are interpreted
using the criteria published by the Clinical and Laboratory
Standards Institute (CLSI, formerly the National Committee
for Clinical Laboratory Standards or NCCLS) [13] or those
included in the US Food and Drug Administration (FDA)
approved product inserts for the disks. The results of the disk
diffusion test are qualitative, in that a category of susceptibility (ie, susceptible, intermediate, or resistant) is derived from
the test rather than an MIC. However, some commerciallyavailable zone reader systems claim to calculate an approximate
MIC with some organisms and antibiotics by comparing zone
sizes with standard curves of that species and drug stored in
an algorithm [14, 15].
Figure 2. A Staphylococcus aureus isolate tested by the Etest gradient diffusion method with vancomycin (VA), daptomycin (DM), and linezolid (LZ)
on Mueller-Hinton agar. The minimum inhibitory concentration of each agent is determined by the intersection of the organism growth with the strip
as measured using the scale inscribed on the strip.
Figure 3. A disk diffusion test with an isolate of Escherichia coli from a urine culture. The diameters of all zones of inhibition are measured and
those values translated to categories of susceptible, intermediate, or resistant using the latest tables published by the CLSI.
5.
8.
References
1. Ericsson JM, Sherris JC. Antibiotic sensitivity testing: report of an
international collaborative study. Acta Pathol Microbiol Scand 1971;
217 (Suppl):190.
2. Jorgensen JH, Turnidge JD. Antibacterial susceptibility tests: dilution
3.
4.
6.
7.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
and disk diffusion methods. In: Murray PR, Baron EJ, Jorgensen JH,
Landry ML, Pfaller MA, eds. Manual of clinical microbiology. 9th ed.
Washington, DC: American Society for Microbiology, 2007:115272.
Balows A. Current techniques for antibiotic susceptibility testing.
Springfield, IL: Charles C. Thomas, 1972.
Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grew aerobically. Approved Standard M7A10. Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
Huang MB, Baker CN, Banerjee S, Tenover FC. Accuracy of the E test
for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to
antimicrobial agents. J Clin Microbiol 1992; 30:32438.
Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended-spectrum cephalosporin
resistance among Streptococcus pneumoniae clinical isolates by use of
the E test. J Clin Microbiol 1994; 32:15963.
Citron, DM, Ostovari MI, Karlsson A, Goldstein EJC. Evaluation of
the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 1991; 29:2197203.
Baker CN, Stocker SA, Culver DM, Thornsberry C. Comparison of
the E-test to agar dilution, broth microdilution, and agar diffusion
susceptibility testing techniques by using a special challenge set of
bacteria. J Clin Microbiol 1991; 29:5338.
Rennie R, Turnbull L, Brosnikoff C. Comparison of Oxoid M.I.C.
Evaluator device with broth microdilution and E test device from AB
Biodisk for antimicrobial susceptibility testing of Enterobacteriaceae
[abstract P859]. In: Program and abstracts of the 18th Annual Meeting
of the European Congress on Clinical Microbiololgy and Infectious
Diseases (Barcelona). European Congress on Clinical Microbiololgy
and Infectious Diseases, 2008.
Prakash V, Lewis JS II, Jorgensen JH. Vancomycin MICs with methicillin-resistant Staphylococcus aureus (MRSA) isolates differ based upon
the susceptibility test method used. Antimicrob Agents Chemother
2008; 52:4528.
Bauer AW, Kirby WMM, Sherris JC, Turk M. Antibiotic susceptibility
testing by a standardized single disk method. Am J Clin Pathol 1966;45:
4936.
Clinical and Laboratory Standards Institute. Performance standards for
antimicrobial disk susceptibility tests. Approved standard M2A10.
Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
Clinical and Laboratory Standards Institute. Performance standards for
antimicrobial susceptibility testing. Nineteenth informational supplement M100S19. Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
Korgenski EK, Daly JA. Evaluation of the BIOMIC video reader for
determining interpretive categories of isolates on the basis of disk diffusion susceptibility results. J Clin Microbiol 1998; 36:3024.
Nijs A, Cartuyvels R, Mewis A, Peeters V, Rummens JL, Magerman K.
Comparison and evaluation of Osiris and Sirscan 2000 antimicrobial
susceptibility systems in the clinical microbiology laboratory. J Clin
Microbiol 2003; 41:362730.
Richter SS, Ferraro MJ. Susceptibility testing instrumentation and computerized expert systems for data analysis and interpretation. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual
of clinical microbiology. 9th ed. Washington, DC: American Society
for Microbiology, 2007:24556.
Doern GV, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in
vitro susceptibility testing and bacterial identification. J Clin Microbiol
1994; 32:175762.
Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of
rapid bacterial identification and antimicrobial susceptibility testing. J
Clin Microbiol 1999; 37:14158.
Jorgensen JH. Selection of antimicrobial agents for routine testing in
a clinical microbiology laboratory. Diagn Microbiol Infect Dis 1993;
16:2459.